Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer and Microsoft target Viagra spammers
The legal actions are the result of a seven-month investigation during which the two companies collaborated to track down the illegal drug distributors operating these websites as well
The legal actions are the result of a seven-month investigation during which the two companies collaborated to track down the illegal drug distributors operating these websites as well
The results show that Nuvigil (armodafinil), a single-isomer of the active pharmaceutical ingredient contained in Cephalon’s Provigil (modafinil), significantly improves wakefulness and the overall clinical condition of patients
The Transdur-based transdermal sufentanil product is intended to provide extended chronic pain relief for up to seven days, as compared to the three days of relief provided with
The ruling was made following a three-day hearing by a board of appeal of the European Patent Office (EPO). Lilly ICOS stated that the decision confirmed the patent’s
HMGene will screen WellGen’s proprietary bioactive compounds against HMGene’s proprietary panel of genes involved in adipocyte development, the body’s natural mechanism for making fat cells. The screening process
For the year ended December 31, 2004, earnings per share were down 9% compared to last year, although Q4 figures showed a 6% increase, which will, no doubt,
“We believe this patent, which combines Akesis’ unique formula of anti-diabetic trace minerals with the widely prescribed sulfonylurea class of medications is an important step in our mission
Although Shire is complying with this request to suspend sales, the company strongly disagrees with the conclusions drawn by Health Canada following the product’s labeling update and is
Rhodia Pharma Solutions will be responsible for the manufacture of active pharmaceutical ingredients used in the production of various formulations of zileuton, including Zyflo filmtab (zileuton tablets), which
Bivatuzumab mertansine consists of the Boehringer Ingelheim anti-CD44v6 antibody, bivatuzumab, and ImmunoGen’s DM1 cytotoxic agent, mertansine. Development of bivatuzumab mertansine was discontinued due to the occurrence of skin